The preclinical studies in cooperation with the University Hospital Vienna were consistently continued in 2022 and achieved positive results that demonstrate and confirm the effectiveness in animal models.
The preclinical studies in cooperation with the University Hospital Vienna were consistently continued in 2022 and achieved positive results that demonstrate and confirm the effectiveness in animal models.
Vaccentis AG,
Gerechtigkeitsgasse 25, CH - 8001 Zürich